Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising effects. However, the expense of this innovative drug and its supply have become key concerns for patients and healthcare professionals. While tirzepatide has been authorized by regulatory agencies, its high-priced nature presents a significant obstacle